Compound Digest

The honest guide to GLP-1s and peptides.

Clear answers on Ozempic, Wegovy, Mounjaro, Zepbound, compounded semaglutide and tirzepatide, plus the peptide world beyond them. Written for people who want to understand what they’re actually taking.

Join 40,000+ readers getting one useful email a week.

Most GLP-1 and peptide content online is bad.

Telehealth companies write blogs to funnel you into their prescriptions. Influencers get paid to push whatever’s trending. Forums are full of guesses dressed up as advice. And almost nobody covers peptides seriously because the space moves faster than mainstream health media can follow.

Meanwhile, you’re trying to figure out real things. Whether tirzepatide is better than semaglutide for your situation. Why you’ve plateaued at month four. If the nausea ever goes away. Whether compounded versions are still legal. What BPC-157 actually does and whether the research supports the hype. How to think about stacking peptides with a GLP-1.

Compound Digest exists to answer those questions the way a smart friend who reads the studies would.

What you’ll get in your inbox

The Weekly Digest. One email every Sunday. The most important GLP-1 and peptide news, studies, and real-user data from the past week, explained in five minutes or less.

Deep dives. Twice a month, a long-form piece on one question worth understanding well. Dosing strategies. Side effects. Compounded versus branded. Peptide research breakdowns. Maintenance after weight loss. The stuff you can’t find answered straight anywhere else.

Reader Q&A. Real questions from readers, answered with actual sources. If you’ve wondered it, someone else has too.

How we work

Every claim links to a source. Every post tells you what we’re confident about, what we’re not, and what the research hasn’t settled yet. When we recommend a product or provider, we tell you why, and we tell you if we earn a commission when you use it.

If we get something wrong, we say so and fix it. You’ll see the correction log at the bottom of every piece we’ve updated.

That’s the bar. We’d rather be trusted than viral.

About Compound Digest

Compound Digest is an independent publication covering GLP-1 medications and peptides for the people taking them or thinking about it.

We started this because the existing internet on this topic is broken. The top Google results are written by companies that profit from your prescription. Social media is a mix of miracle stories and horror stories with no way to tell what’s representative. Peptide coverage barely exists outside niche forums. Your doctor has eight minutes.

We write the stuff we wish existed when we started paying attention to this space. What the studies actually say. What real users are reporting. What’s changed this week. What to ask your provider. What the trade-offs are.